Dr Ilisa B. G. Bernstein joins Ethics Talk to discuss her article, coauthored with Karin L. Bolte: “Is My Patient Taking an Unsafe Dietary Supplement?”
Elizabeth Richardson joins Ethics Talk to discuss her article, coauthored Farzana Akkas and Dr Amy B. Cadwallader: “What Should Dietary Supplement Oversight Look Like in the US?”
Dr Alexander Ding joins Ethics Talk to discuss his article, coauthored with Dr Amy B. Cadwallader and other members of the AMA Council on Science and Public Health: “Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention?”
Dr. Jones has a duty to determine how the test results were lost and why, disclose this information to his patient, Mrs. Taylor, and see that she is not held responsible for the costs of rerunning the test.
After years of funding disease-specific treatment, donation trends have shifted to support broader health systems infrastructure development. A remaining challenge is how to sustain antiretroviral therapy (ART) for patients in resource-poor regions.
AMA J Ethics. 2016;18(7):681-690. doi:
10.1001/journalofethics.2016.18.7.ecas3-1607.
Allopathic clinicians should treat local health practitioners as equal partners in cross-cultural clinical practice and express respect for traditional therapies.
AMA J Ethics. 2016;18(7):691-697. doi:
10.1001/journalofethics.2016.18.7.ecas4-1607.